Literature DB >> 31464016

Beneficial effects of celery (Apium graveolens) on metabolic syndrome: A review of the existing evidences.

Narges Hedayati1,2, Mehri Bemani Naeini3, Arash Mohammadinejad1,4,2, Seyed Ahmad Mohajeri1,2.   

Abstract

The metabolic syndrome (MetS) is a cluster of multiple conditions that includes hypertension, dyslipidemia, abdominal obesity, and hyperglycemia disorders. Most studies revealed that the MetS is accompanied with an increased risk for cardiovascular disease, Type 2 diabetes mellitus, and insulin resistance. It can be said that, in treating or preventing the MetS and its components, lifestyle adjustment and weight loss have a vital role. According to various studies, among natural compounds, celery (Apium graveolens) is one of the most important sources of phytochemicals such as phenolic acids, flavones, flavonols, and antioxidants such as vitamin C, beta-carotene (Provitamin A), and manganese. These antioxidants have a role in decreasing the oxidative damage. The phytochemicals in celery decrease the activity of proinflammatory cytokines and prevent inflammation. Also, flavonoids in celery suppress cardiovascular inflammation. Oxidative stress and inflammation in the blood stream are the main risk factors in increasing cardiovascular disease, especially atherosclerosis. Celery phthalides leads to expanding of smooth muscle in the blood vessels and lower blood pressure. As a result, the most active ingredients in celery (A. graveolens (have shown hypolipidemic, antidiabetic, and hypotensive properties. In this review, we summarized the mechanisms underlying the protective effects of celery components on insulin action, glucose, lipid metabolism, and blood pressure.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Apium graveolens; dyslipidemia; hyperglycemia; hypertension; metabolic syndrome; obesity

Mesh:

Year:  2019        PMID: 31464016     DOI: 10.1002/ptr.6492

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

1.  Safety evaluation and biochemical efficacy of celery seed extract (Apium Graveolens) capsules in hypertensive patients: a randomized, triple-blind, placebo-controlled, cross-over, clinical trial.

Authors:  Maryam Shayani Rad; Mohsen Moohebati; Shahab MohammadEbrahimi; Vahideh Sadat Motamedshariaty; Seyed Ahmad Mohajeri
Journal:  Inflammopharmacology       Date:  2022-05-10       Impact factor: 5.093

Review 2.  Type 2 Diabetes Mellitus in Latinx Populations in the United States: A Culturally Relevant Literature Review.

Authors:  Therese M Vidal; Caitlin A Williams; Uma D Ramoutar; Farzanna Haffizulla
Journal:  Cureus       Date:  2022-03-15

3.  Evaluation of Anti-Inflammatory Effects of Celery Leaf and Stem Extracts in LPS-Induced RAW 264.7 Cells Using Nitric Oxide Assay and LC-MS Based Metabolomics.

Authors:  Hazel Lau; Nengyi Ni; Hiranya Dayal; Si-Ying Lim; Yi Ren; Sam Fong-Yau Li
Journal:  Curr Issues Mol Biol       Date:  2021-11-05       Impact factor: 2.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.